Premium
Pancreaticoduodenectomies with a duct‐to‐mucosa pancreaticojejunostomy anastomosis with and without a stenting tube showed no differences in long‐term follow‐up
Author(s) -
Suzuki Shuji,
Kaji Satoshi,
Koike Nobusada,
Harada Nobuhiko,
Hayashi Tsuneo,
Suzuki Mamoru,
Imaizumi Toshihide,
Hanyu Fujio
Publication year - 2011
Publication title -
journal of hepato‐biliary‐pancreatic sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 1868-6974
DOI - 10.1007/s00534-010-0339-4
Subject(s) - medicine , pancreaticoduodenectomy , anastomosis , surgery , pancreatic duct , complication , gastroenterology , duct (anatomy) , pancreatitis , resection
Abstract Background/purpose The aim of this study was to evaluate the long‐term complications of pancreaticoduodenectomy with a duct‐to‐mucosa pancreaticojejunostomy anastomosis without a stenting tube. Methods Patients were followed for at least 3 years after pancreaticoduodenectomy. They were classified into two groups: duct‐to‐mucosa pancreaticojejunostomy anastomosis with a stenting tube (group A: 24) and without a stenting tube (group B: 21). Outcomes, including complications and dilatation of the pancreatic duct, were reported retrospectively. Results The following complication rates were found for group A: morbidity 29.1%, cholangitis 12.5%, nonalcoholic steatohepatitis 4.2%, liver abscess 4.2%, intrahepatic stones 4.2%, abnormal glucose tolerance (progression of diabetes) 20.8%, and dilatation of the pancreatic duct 20.8%. In group B, the rates for morbidity (14.3%) and abnormal glucose tolerance (19%), and dilatation of the pancreatic duct (4.8%) were lower than those in group A, but all results lacked statistical significance. Conclusions Pancreaticoduodenectomy with a duct‐to‐mucosa anastomosis of pancreaticojejunostomy with or without a stenting tube showed no difference in long‐term follow‐up.